Myriad CEO to Retire; Company Cuts Guidance

Myriad Genetics Inc. Chief Executive Peter Meldrum said he will retire from the molecular diagnostics company he co-founded nearly 25 years ago, and the company separately said it was lowering its full-year sales guidance.



from WSJ.com: US Business http://ift.tt/1yErc67

via IFTTT